DR. PRASAD S ADUSUMILLI, M.D.
Radiology at York Ave, New York, NY

License number

New York 243840

Personal information

See more information about PRASAD S ADUSUMILLI at radaris.com

Name

Address

Phone

Prasad Adusumilli, age 59

530 E 76Th St APT 27K, New York, NY 10021

(212) 371-2205

Prasad S Adusumilli

504 E 63Rd St, New York, NY 10065

(212) 371-2205

Prasad S Adusumilli, age 59

312 66Th St, New York, NY 10021

(212) 535-4636

Prasad S Adusumilli

312 E 76Th St #4C, New York, NY 10021

(212) 535-4636

Prasad S Adusumilli, age 59

48 End Ave, New York, NY 10028

(212) 535-4636

Organization information

See more information about PRASAD S ADUSUMILLI at bizstanding.com

Prasad S Adusumilli MD

1275 York Ave #C-877, New York, NY 10065

Categories:

Physicians & Surgeons

Phone:

(212) 639-2000 (Phone)

Professional information

See more information about PRASAD S ADUSUMILLI at trustoria.com

Dr. Prasad Adusumilli, New York NY - MD (Doctor of Medicine)

Specialties:

Cardiac Surgery

Address:

MSKCC SURGERY GROUP
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
MSKCC
1275 York Ave, New York 10065
(866) 425-8999 (Phone)

Conditions:

Congestive Heart Failure, Esophageal Cancer, Lung Cancer

Certifications:

General Surgery, 2005, Thoracic Cardiovascular Surgery, 2011

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

MSKCC SURGERY GROUP
1275 York Ave, New York 10065
MSKCC
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065

Philosophy:

I am a general thoracic surgeon specializing in thoracic cancers; including lung cancer, esophageal cancer, mesothelioma, mediastinal tumors, and metastases to the lungs. My clinical interests include minimally invasive surgery for early-stage lung and esophageal cancers, and palliative surgical therapies for advanced-stage cancers. I conduct laboratory research with a focus on developing gene therapies for thoracic cancers. These therapies include immunotherapy (enhancing one's own immune system using genetic engineering) and oncolytic viral therapy (killing cancer cells using genetically engineered viruses). This research has been supported by the American Association for Cancer Research, the Susan G. Komen Breast Cancer Foundation, the Flight Attendent Medical Research Institute, and the American Geriatric Society.

Education:

Medical School
Guntur Medical College, Ntr University Of Health Sciences
Graduated: 1989
Maimonides Medical Center
Lenox Hill Hospital
University Pittsburgh Medical Center

Principal Scientist At Gsk

Position:

Principal Scientist at GSK, Principal Scientist at GlaxoSmithKline Consumer Healthcare, Principal Scientist at Glaxo SmithKline Consumer Healthcare, Principal Scientist at GlaxoSmithKline

Location:

Greater New York City Area

Industry:

Pharmaceuticals

Work:

GSK since Aug 2011 - Principal Scientist GlaxoSmithKline Consumer Healthcare since 2006 - Principal Scientist Glaxo SmithKline Consumer Healthcare since 2004 - Principal Scientist GlaxoSmithKline since 1990 - Principal Scientist

Education:

Fairleigh Dickinson University 2007 - 2009
MBA, Management Saint John's University 1981 - 1990

Assistant Attending At Memorial Sloan-Kettering Cancer Center

Position:

Assistant Attending at Memorial Sloan-Kettering Cancer Center

Location:

Greater New York City Area

Industry:

Hospital & Health Care

Work:

Memorial Sloan-Kettering Cancer Center - Assistant Attending

Prasad S Adusumilli, New York NY

Specialties:

Cardiothoracic Surgeon

Address:

1275 York Ave, New York, NY 10065

Education:

Doctor of Medicine
UPMC Montefiore - Fellowship - Cardiothoracic Surgery
Lenox Hill Hospital - Residency - Surgery

Board certifications:

American Board of Surgery Certification in Surgery, American Board of Thoracic Surgery Certification in Thoracic and Cardiac Surgery (Thoracic Surgery)

Method For Detection Of Cancer Cells Using Virus

US Patent:

2009031, Dec 17, 2009

Filed:

Dec 21, 2006

Appl. No.:

12/086805

Inventors:

Yuman Fong - New York NY, US
Prasad Adusumilli - New York NY, US

International Classification:

C12Q 1/70

US Classification:

435 5

Abstract:

The invention relates to compositions and methods for cancer cell detection in bodily samples wherein a cancer cell can be detected within a mixed population of cancer cells and non-cancer cells. The invention also relates to compositions and methods that may be used in cancer cell detection, specifically viruses that are replication-competent conditional to a cancer cell, in particular an oncolytic herpes virus, such as NV 1066 and a vaccinia virus, such as GLV-1h68. Provided are methods and kits for using these viruses that preferentially replicate in cancer cells and may also preferentially infect cancer cells for specific identification of such cancer cells, even when a cancer cell is present, for example, at a ratio of one infected cancer cell in a background often thousand non-cancer cells, thus further providing a reproducible and sensitive screening method for cancer detection, monitoring and prognosis.

Handheld Apparatus To Determine The Viability Of A Biological Tissue

US Patent:

2011022, Sep 15, 2011

Filed:

Jul 22, 2009

Appl. No.:

13/054862

Inventors:

Jaafar Tindi - Bronx NY, US
Farah Khan - Shrewsbury MA, US
Christopher D. Hue - Flushing NY, US
Chinedu Chukuigwe - New York NY, US
Saumya Banerjee - Flushing NY, US
Rohan Shah - Edison NY, US
Alina Levchuck - Edgewater NJ, US
Marom Bikson - Brooklyn NY, US
Luis Cardoso - New York NY, US
Prasad Adusumilli - New York NY, US
Nabil Rizk - Mamaroneck NY, US
Luis Carlos Oliveira - Newark NJ, US
Varun Bansai - Maspeth NY, US

International Classification:

A61B 5/1459, A61B 6/00

US Classification:

600323, 600407, 600310

Abstract:

The present invention provides for a handheld apparatus for in vivo examination of the viability of a biological tissue.